WT1 peptide cancer vaccine composition for transdermal administration

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10071051
APP PUB NO 20140220057A1
SERIAL NO

14166950

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a cancer vaccine composition for transdermal administration for cellular immunity induction, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a pharmacologically acceptable acid as a first cellular immunity induction promoter, or a pharmacologically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NITTO DENKO CORPORATION; OSAKA UNIVERSITY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asari, Daisuke Osaka, JP 51 236
Hori, Mitsuhiko Osaka, JP 64 328
Maeda, Yoshiki Osaka, JP 33 269
Okazaki, Arimichi Osaka, JP 28 213
Okubo, Katsuyuki Osaka, JP 37 420
Shishido, Takuya Osaka, JP 37 161
Sugiyama, Haruo Osaka, JP 113 1386

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 11, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 11, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00